CVRx, Inc. (NASDAQ: CVRX) ('CVRx”), a commercial-stage medical device company focused on developing, manufacturing and ...
Koelis, SAS (“Koelis” or the “Company”, a leader and innovator in MRI-ultrasound fusion guidance for prostate cancer interventions, recently announced that the Centers for Medicare & Medicaid ...
Koelis, SAS (“Koelis” or the “Company”, a leader and innovator in MRI-ultrasound fusion guidance for prostate cancer ...
The new CPT code reflects the latest efficacious medical care available to patients, facilitating adoption and utilization.The assignment of a ...
Fourth quarter revenue expected to be $15.9 million to $16.1 million, representing growth of 4% to 5%Full year revenue expected to be $56.5 ...
Elucid today announced that, effective January 1, 2026, its Plaque-IQ(TM) coronary plaque analysis has received a new Category I Current Procedural Terminology (CPT(R)) designation, alongside ...
Regional variations in market growth reflect differences in healthcare infrastructure and adoption rates, with North America and Asia-Pacific leading the way. Companies operating in the market ...
Contrast media used for medical imaging may be contributing to environmental pollution as researchers measure and consider the impact.
The latest research on 3D Systems has shifted the story around the stock, with a new price target of US$4.75 now setting the ...
Fourth major national payer releases positive comprehensive coverage for AI-powered Heartflow Plaque AnalysisMOUNTAIN VIEW, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) ...
WASHINGTON, DC - The American College of Surgeons (ACS) and 33 medical organizations asked the United States Congress Monday ...
Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results